Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Sodium"" wg kryterium: Temat


Starter badań:

Tytuł :
Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitors.
Autorzy :
Herrington WG; Medical Research Council Population Health Research Unit at the University of Oxford, part of the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.; Oxford Kidney Unit, Churchill Hospital, Oxford, UK.
Savarese G; Cardiology Unit, Department of Medicine, Karolinska Institute: Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.
Haynes R; Medical Research Council Population Health Research Unit at the University of Oxford, part of the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.; Oxford Kidney Unit, Churchill Hospital, Oxford, UK.
Marx N; Department of Internal Medicine, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
Mellbin L; Cardiology Unit, Department of Medicine, Karolinska Institute: Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.
Lund LH; Cardiology Unit, Department of Medicine, Karolinska Institute: Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.
Dendale P; Heart Centre Hasselt, Jessa Hospital, Hasselt, Belgium.; Faculty of Medicine & Life Sciences, Hasselt University, Hasselt, Belgium.
Seferovic P; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Rosano G; Department of Medical Sciences, IRCCS San Raffaele Pisana, Rome, Italy.
Staplin N; Medical Research Council Population Health Research Unit at the University of Oxford, part of the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.
Baigent C; Medical Research Council Population Health Research Unit at the University of Oxford, part of the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.
Cosentino F; Cardiology Unit, Department of Medicine, Karolinska Institute: Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.
Pokaż więcej
Źródło :
European journal of heart failure [Eur J Heart Fail] 2021 Aug; Vol. 23 (8), pp. 1260-1275. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Cardiology*
Diabetes Mellitus, Type 2*/drug therapy
Heart Failure*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*
Glucose ; Humans ; Sodium ; Sodium-Glucose Transporter 2
Czasopismo naukowe
Tytuł :
Renal haemodynamic response to sodium-glucose cotransporter-2 inhibition does not depend on protein intake: An analysis of three randomized controlled trials.
Autorzy :
van der Aart-van der Beek AB; Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, The Netherlands.; Clinical Pharmacy, Martini Hospital, Groningen, The Netherlands.
Cherney D; Division of Nephrology, Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada.
Laverman GD; Department of Internal Medicine, ZGT Hospital, Almelo and Hengelo, The Netherlands.
Stefansson B; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
van Raalte DH; Diabetes Centre, Department of Internal Medicine, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands.
Hoogenberg K; Internal Medicine, University of Groningen, Groningen, The Netherlands.
Reyner D; R&D Bio Pharmaceuticals, Late CVRM, AstraZeneca, Gaithersburg, Maryland, USA.
Li Q; George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
Di Tanna GL; George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
Greasley PJ; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Heerspink HJL; Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, The Netherlands.; George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło :
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2021 Aug; Vol. 23 (8), pp. 1961-1967. Date of Electronic Publication: 2021 May 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Benzhydryl Compounds ; Dietary Proteins ; Glomerular Filtration Rate ; Glucose ; Hemodynamics ; Humans ; Kidney ; Randomized Controlled Trials as Topic ; Sodium ; Sodium-Glucose Transporter 2
Czasopismo naukowe
Tytuł :
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure, Regardless of Diabetes Status: Focus on Cardiovascular Disease.
Autorzy :
Ferrari F; Postgraduate Program in Cardiology and Cardiovascular Sciences, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul School of Medicine, Porto Alegre, RS, Brazil.; Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Martins VM; Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Scheffel RS; Department of Pharmacology, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.; Endocrine Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul School of Medicine, Porto Alegre, RS, Brazil.
da Silveira AD; Postgraduate Program in Cardiology and Cardiovascular Sciences, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul School of Medicine, Porto Alegre, RS, Brazil.; Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Motta MT; Universidade Estadual de Feira de Santana, Feira de Santana, BA, Brazil.
Moriguchi EH; Postgraduate Program in Cardiology and Cardiovascular Sciences, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul School of Medicine, Porto Alegre, RS, Brazil.; School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Santos RD; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.; Lipid Clinic, Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Stein R; Postgraduate Program in Cardiology and Cardiovascular Sciences, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul School of Medicine, Porto Alegre, RS, Brazil.; School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Pokaż więcej
Źródło :
The Annals of pharmacotherapy [Ann Pharmacother] 2021 Oct; Vol. 55 (10), pp. 1267-1275. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cardiovascular Diseases*/epidemiology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Heart Failure*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*
Glucose ; Humans ; Sodium ; Stroke Volume
Czasopismo naukowe
Tytuł :
Do sodium-glucose co-transporter-2 inhibitors increase plasma glucagon by direct actions on the alpha cell? And does the increase matter for the associated increase in endogenous glucose production?
Autorzy :
Kuhre RE; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Obesity Pharmacology, Novo Nordisk, Måløv, Denmark.
Deacon CF; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; School of Biomedical Sciences, Ulster University, Coleraine, UK.
Wewer Albrechtsen NJ; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Holst JJ; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Novo Nordisk Foundation Centre for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło :
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2021 Sep; Vol. 23 (9), pp. 2009-2019. Date of Electronic Publication: 2021 May 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Diabetes Mellitus, Type 2*/drug therapy
Pharmaceutical Preparations*
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Benzhydryl Compounds ; Blood Glucose ; Glucagon ; Glucose ; Glucosides ; Humans ; Sodium
Czasopismo naukowe
Tytuł :
Impact of the initial decline in estimated glomerular filtration rate on the risk of new-onset atrial fibrillation and adverse cardiovascular and renal events in patients with type 2 diabetes treated with sodium-glucose co-transporter-2 inhibitors.
Autorzy :
Chan YH; The Cardiovascular Department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Microscopy Core Laboratory, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
Chen SW; Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Chang Gung University, Taoyuan City, Taiwan.; Center for Big Data Analytics and Statistics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Chao TF; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Clinical Medicine, Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Kao YW; Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan.
Huang CY; The Cardiovascular Department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
Chu PH; The Cardiovascular Department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Pokaż więcej
Źródło :
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2021 Sep; Vol. 23 (9), pp. 2077-2089. Date of Electronic Publication: 2021 Jun 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Atrial Fibrillation*/drug therapy
Atrial Fibrillation*/epidemiology
Brain Ischemia*
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Stroke*/chemically induced
Stroke*/epidemiology
Stroke*/prevention & control
Symporters*
Aged ; Female ; Glomerular Filtration Rate ; Glucose ; Humans ; Sodium
Czasopismo naukowe
Tytuł :
Why are sodium channel modulators not yet pharmacotherapeutic trailblazers for neuropathic pain?
Autorzy :
Dickenson A; Neuroscience, Physiology and Pharmacology, University College London, London, UK.
Pokaż więcej
Źródło :
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2021 Sep; Vol. 22 (13), pp. 1635-1637. Date of Electronic Publication: 2021 Apr 26.
Typ publikacji :
Editorial
MeSH Terms :
Analgesics*/therapeutic use
Neuralgia*/drug therapy
Sodium Channel Blockers*/therapeutic use
Humans ; Sodium Channels
Opinia redakcyjna
Tytuł :
Are All SGLT2 Inhibitors Created Equal?
Autorzy :
Gregg LP; Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas.; Section of Nephrology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.; Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas.
Navaneethan SD; Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas .; Section of Nephrology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.; Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas.; Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas.
Pokaż więcej
Źródło :
Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2021 Sep; Vol. 16 (9), pp. 1309-1311.
Typ publikacji :
Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Comment
MeSH Terms :
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Humans ; Hypoglycemic Agents/adverse effects ; Sodium-Glucose Transporter 2
Raport
Tytuł :
Growth Differentiation Factor-15 Produces Analgesia by Inhibiting Tetrodotoxin-Resistant Nav1.8 Sodium Channel Activity in Rat Primary Sensory Neurons.
Autorzy :
Lin W; Department of Translational Neuroscience, Jing'an District Centre Hospital of Shanghai, State Key Laboratory of Medical Neurobiology and Institutes of Brain Science, Fudan University, Shanghai, 200032, China.
Zhang WW; Department of Translational Neuroscience, Jing'an District Centre Hospital of Shanghai, State Key Laboratory of Medical Neurobiology and Institutes of Brain Science, Fudan University, Shanghai, 200032, China.
Lyu N; Department of Translational Neuroscience, Jing'an District Centre Hospital of Shanghai, State Key Laboratory of Medical Neurobiology and Institutes of Brain Science, Fudan University, Shanghai, 200032, China. .
Cao H; Department of Translational Neuroscience, Jing'an District Centre Hospital of Shanghai, State Key Laboratory of Medical Neurobiology and Institutes of Brain Science, Fudan University, Shanghai, 200032, China.
Xu WD; Department of Translational Neuroscience, Jing'an District Centre Hospital of Shanghai, State Key Laboratory of Medical Neurobiology and Institutes of Brain Science, Fudan University, Shanghai, 200032, China. .; Department of Hand Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, China. .
Zhang YQ; Department of Translational Neuroscience, Jing'an District Centre Hospital of Shanghai, State Key Laboratory of Medical Neurobiology and Institutes of Brain Science, Fudan University, Shanghai, 200032, China. .; Department of Neurobiology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China. .
Pokaż więcej
Źródło :
Neuroscience bulletin [Neurosci Bull] 2021 Sep; Vol. 37 (9), pp. 1289-1302. Date of Electronic Publication: 2021 Jun 02.
Typ publikacji :
Journal Article
MeSH Terms :
Analgesia*
NAV1.8 Voltage-Gated Sodium Channel*
Animals ; Ganglia, Spinal ; Growth Differentiation Factor 15 ; Rats ; Sensory Receptor Cells ; Sodium Channels ; Tetrodotoxin/pharmacology
Czasopismo naukowe
Tytuł :
High-dose sodium-glucose co-transporter-2 inhibitors are superior in type 2 diabetes: A meta-analysis of randomized clinical trials.
Autorzy :
Shi FH; Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Li H; Department of Pharmacy, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Clinical Research Center, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Shen L; Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Fu JJ; Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Ma J; Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Gu ZC; Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Lin HW; Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.; School of Medicine, Tongji University, Shanghai, China.
Pokaż więcej
Źródło :
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2021 Sep; Vol. 23 (9), pp. 2125-2136. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Symporters*
Blood Glucose ; Humans ; Hypoglycemic Agents/therapeutic use ; Male ; Middle Aged ; Randomized Controlled Trials as Topic ; Sodium
Czasopismo naukowe
Tytuł :
Dietary Sodium and Potassium Intake in Hungarian Elderly: Results from the Cross-Sectional Biomarker2019 Survey.
Autorzy :
Sarkadi-Nagy E; Department of Nutritional Epidemiology, National Institute of Pharmacy and Nutrition, Albert Flórián út 3/A, 1097 Budapest, Hungary.
Horváth A; Department of Nutritional Epidemiology, National Institute of Pharmacy and Nutrition, Albert Flórián út 3/A, 1097 Budapest, Hungary.
Varga A; Department of Nutritional Epidemiology, National Institute of Pharmacy and Nutrition, Albert Flórián út 3/A, 1097 Budapest, Hungary.
Zámbó L; Department of Nutritional Epidemiology, National Institute of Pharmacy and Nutrition, Albert Flórián út 3/A, 1097 Budapest, Hungary.
Török A; Department of Nutritional Epidemiology, National Institute of Pharmacy and Nutrition, Albert Flórián út 3/A, 1097 Budapest, Hungary.
Guba G; Department of Nutritional Epidemiology, National Institute of Pharmacy and Nutrition, Albert Flórián út 3/A, 1097 Budapest, Hungary.
Szilfai N; Department of Nutritional Epidemiology, National Institute of Pharmacy and Nutrition, Albert Flórián út 3/A, 1097 Budapest, Hungary.
Zentai A; Department of Nutritional Epidemiology, National Institute of Pharmacy and Nutrition, Albert Flórián út 3/A, 1097 Budapest, Hungary.
Bakacs M; Department of Nutritional Epidemiology, National Institute of Pharmacy and Nutrition, Albert Flórián út 3/A, 1097 Budapest, Hungary.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Aug 20; Vol. 18 (16). Date of Electronic Publication: 2021 Aug 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Sodium, Dietary*/analysis
Aged ; Cross-Sectional Studies ; Female ; Humans ; Hungary ; Male ; Potassium ; Potassium, Dietary ; Sodium Chloride, Dietary
Czasopismo naukowe
Tytuł :
Sodium-glucose cotransporter-2 inhibitors for heart failure with reduced ejection fraction.
Autorzy :
Falk J; Associate Professor in the College of Pharmacy at the University of Manitoba in Winnipeg.
Potter J; Family physician in Winnipeg.
Turgeon RD; Assistant Professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia in Vancouver.
Pokaż więcej
Źródło :
Canadian family physician Medecin de famille canadien [Can Fam Physician] 2021 Sep; Vol. 67 (9), pp. 678.
Typ publikacji :
Journal Article
MeSH Terms :
Diabetes Mellitus, Type 2*/drug therapy
Heart Failure*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Glucose ; Humans ; Sodium ; Stroke Volume
Czasopismo naukowe
Tytuł :
Ion-poor water and dietary salt deprivation upregulate the ghrelinergic system in the goldfish (Carassius auratus).
Autorzy :
Lim Y; Department of Biology, York University, Toronto, Ontario, Canada.
Lee V; Department of Biology, York University, Toronto, Ontario, Canada.
Blanco A; Laboratory of Integrative Neuroendocrinology, Department of Veterinary Biomedical Sciences, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Kelly SP; Department of Biology, York University, Toronto, Ontario, Canada.
Unniappan S; Laboratory of Integrative Neuroendocrinology, Department of Veterinary Biomedical Sciences, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Pokaż więcej
Źródło :
Journal of fish biology [J Fish Biol] 2021 Sep; Vol. 99 (3), pp. 1100-1109. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji :
Journal Article
MeSH Terms :
Goldfish*
Sodium Chloride, Dietary*
Animals ; Gills/metabolism ; Sodium-Potassium-Exchanging ATPase/metabolism ; Water
Czasopismo naukowe
Tytuł :
Sodium-glucose co-transporter-2 inhibitors and protection from cardiovascular death: Is it all about heart failure?
Autorzy :
Caruso I; Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.
Cignarelli A; Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.
Laviola L; Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.
Giorgino F; Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.
Pokaż więcej
Źródło :
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2021 Sep; Vol. 23 (9), pp. 2194-2196. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Letter
MeSH Terms :
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Heart Failure*/prevention & control
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Symporters*
Glucose ; Humans ; Sodium
Opinia redakcyjna
Tytuł :
Risk of diabetic macular oedema with sodium-glucose cotransporter-2 inhibitors in type 2 diabetes patients: A multi-institutional cohort study in Taiwan.
Autorzy :
Su YC; Department of Ophthalmology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Shao SC; Department of Pharmacy, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Lai EC; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Lee CN; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Hung MJ; College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung, Taiwan.
Lai CC; College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Department of Ophthalmology, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
Hsu SM; Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Hung JH; Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Pokaż więcej
Źródło :
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2021 Sep; Vol. 23 (9), pp. 2067-2076. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Macular Edema*/chemically induced
Macular Edema*/epidemiology
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Adult ; Glucose ; Humans ; Hypoglycemic Agents/adverse effects ; Infant ; Retrospective Studies ; Sodium ; Taiwan/epidemiology
Czasopismo naukowe
Tytuł :
Case of sodium-glucose cotransporter-2 inhibitor-associated euglycaemic diabetic ketoacidosis.
Autorzy :
Yeoh HL; Pharmacy Department, Mount Elizabeth Novena Hospital, Singapore .
Lee M; Mount Elizabeth Novena Hospital, Singapore.
Pan WJ; Mount Elizabeth Novena Hospital, Singapore.
Ong HY; Mount Elizabeth Novena Hospital, Singapore.
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 Aug 17; Vol. 14 (8). Date of Electronic Publication: 2021 Aug 17.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetic Ketoacidosis*/chemically induced
Diabetic Ketoacidosis*/diagnosis
Diabetic Ketoacidosis*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Glucose ; Humans ; Male ; Middle Aged ; Sodium
Czasopismo naukowe
Tytuł :
Sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: reasons for optimism.
Autorzy :
Anker SD; Berlin Institute of Health Center for Regenerative Therapies (BCRT) and Department of Cardiology (CVK) - German Centre for Cardiovascular Research (DZHK) partner site Berlin - University Medicine Berlin, Berlin, Germany.
Khan MS; Division of Cardiology, Duke University School of Medicine, Durham, NC, USA.
Shahid I; Department of Medicine, Ziauddin University, Karachi, Pakistan.
Filippatos G; National and Kapodistrian University of Athens School of Medicine, Athens University Hospital Attikon, Athens, Greece.
Coats AJS; University of Warwick, Coventry, UK.
Butler J; Department of Medicine, University of Mississippi, Jackson, Mississippi, USA.
Pokaż więcej
Źródło :
European journal of heart failure [Eur J Heart Fail] 2021 Aug; Vol. 23 (8), pp. 1250-1255. Date of Electronic Publication: 2021 Jul 26.
Typ publikacji :
Journal Article
MeSH Terms :
Heart Failure*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Symporters*
Glucose ; Humans ; Sodium ; Stroke Volume
Czasopismo naukowe
Tytuł :
Sodium-glucose co-transporter 2 inhibitors-the first successful treatment for heart failure with preserved ejection fraction?
Autorzy :
Petrie MC; British Heart Foundation Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.; Glasgow Royal Infirmary, Glasgow, UK.
Lee MMY; British Heart Foundation Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.; Glasgow Royal Infirmary, Glasgow, UK.
Docherty KF; British Heart Foundation Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Pokaż więcej
Źródło :
European journal of heart failure [Eur J Heart Fail] 2021 Aug; Vol. 23 (8), pp. 1256-1259. Date of Electronic Publication: 2021 Feb 08.
Typ publikacji :
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Heart Failure*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Symporters*
Glucose ; Humans ; Sodium ; Stroke Volume
Raport
Tytuł :
Two cases of euglycemic diabetic ketoacidosis after bariatric surgery associated with sodium-glucose cotransporter-2 inhibitor use.
Autorzy :
Amianda EA; Center for Bariatric Medicine and Surgery, Hackensack University Medical Center, 20 Prospect Avenue, Suite 703, Hackensack, NJ, 07601, USA. .
Gavigan TS; Center for Bariatric Medicine and Surgery, Hackensack University Medical Center, 20 Prospect Avenue, Suite 703, Hackensack, NJ, 07601, USA.
Talishinskiy T; Center for Bariatric Medicine and Surgery, Hackensack University Medical Center, 20 Prospect Avenue, Suite 703, Hackensack, NJ, 07601, USA.
Ewing DR; Center for Bariatric Medicine and Surgery, Hackensack University Medical Center, 20 Prospect Avenue, Suite 703, Hackensack, NJ, 07601, USA.
Schmidt HJ; Center for Bariatric Medicine and Surgery, Hackensack University Medical Center, 20 Prospect Avenue, Suite 703, Hackensack, NJ, 07601, USA.
Pokaż więcej
Źródło :
Obesity surgery [Obes Surg] 2021 Aug; Vol. 31 (8), pp. 3848-3850. Date of Electronic Publication: 2021 Apr 24.
Typ publikacji :
Letter
MeSH Terms :
Bariatric Surgery*/adverse effects
Diabetes Mellitus, Type 2*/drug therapy
Diabetic Ketoacidosis*/chemically induced
Obesity, Morbid*/surgery
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Glucose ; Humans ; Sodium
Opinia redakcyjna
Tytuł :
Salbutamol and salt-sensitive hypertension.
Autorzy :
Bailey MA; British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK. Electronic address: .
Pokaż więcej
Źródło :
Kidney international [Kidney Int] 2021 Aug; Vol. 100 (2), pp. 272-275.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Hypertension*/chemically induced
Hypertension*/drug therapy
Sodium Chloride, Dietary*
Albuterol/adverse effects ; Animals ; Humans ; Kidney Tubules, Distal ; Mice ; Sodium Chloride ; Solute Carrier Family 12, Member 3
Czasopismo naukowe
Tytuł :
Effect of Monosodium Glutamate on Saltiness and Palatability Ratings of Low-Salt Solutions in Japanese Adults According to Their Early Salt Exposure or Salty Taste Preference.
Autorzy :
Morita R; Graduate School of Health and Environmental Sciences, Fukuoka Women's University, Fukuoka 813-8529, Japan.
Ohta M; Graduate School of Health and Environmental Sciences, Fukuoka Women's University, Fukuoka 813-8529, Japan.
Umeki Y; Graduate School of Health and Environmental Sciences, Fukuoka Women's University, Fukuoka 813-8529, Japan.
Nanri A; Graduate School of Health and Environmental Sciences, Fukuoka Women's University, Fukuoka 813-8529, Japan.
Tsuchihashi T; Steel Memorial Yawata Hospital, Kitakyushu, Fukuoka 805-8508, Japan.
Hayabuchi H; Department of Food Science and Nutrition, Faculty of Human Life and Environment, Nara Women's University, Nara 630-8506, Japan.
Pokaż więcej
Źródło :
Nutrients [Nutrients] 2021 Feb 09; Vol. 13 (2). Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :
Journal Article
MeSH Terms :
Diet, Sodium-Restricted*
Food Preferences*
Sodium, Dietary*
Sodium Glutamate/*administration & dosage
Taste/*drug effects
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Japan ; Male ; Middle Aged ; Sodium Chloride/administration & dosage ; Solutions ; Taste Perception
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies